Martine Zimmerman

SVP, Head of Global Regulatory affairs and R&D Quality SVP at Ipsen

Speaker

Martine Zimmermann joined Ipsen in January 2023 as Senior Vice President and Head of Regulatory & Quality Affairs, based in Boulogne (France). Previously she was Senior Vice President and Head of Regulatory & Quality Affairs at Alexion, AstraZeneca Rare Disease. Dr Zimmermann has over 25 years of combined R&D and global regulatory strategy experience. She joined Alexion Pharmaceuticals (part of AstraZeneca since 2021) in 2009 and has since then been dedicated to the registration of several orphan medicinal products across the globe, as well as to the shaping of the regulatory environment for medicines under development for rare diseases. Prior to Alexion Pharmaceuticals, Dr Zimmermann held numerous R&D and regulatory roles in companies such as Aventis (now Sanofi), Servier and H. Lundbeck A/S. Dr Zimmermann also serves currently as a Director in the Board of Inventiva Pharma, and previously in the Board of Caelum Biosciences (now part of AstraZeneca). Dr. Zimmermann has also held several external roles and is currently a member of the Board of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE). Martine has been a champion of diversity, equality, inclusion and belonging, having been recognized by the Healthcare Businesswoman’s Association as a Luminary in 2020, and efforts by serving as an executive sponsor for Alexion’s flagship Women In Leadership (WIL) employee resource group. Martine is also internally and externally engaged in important initiatives, being Alexion’s Sustainability Leadership sponsor. She received her PharmD from the University Louis Pasteur in Strasbourg, France.